|
 Home: PCU
4|2003: Faculty Disclosures
FACULTY DISCLOSURES
As a provider accredited by the ACCME, it is the policy of NL Communications
to require the
disclosure of any significant financial interest or any other relationship
the sponsor or faculty
members have with the manufacturer(s) of any commercial product(s) discussed
in an educational
presentation. The presenting faculty reported the following:
|
Mack Roach III, MD |
Grants/Research Support: Berlex Laboratories Inc, Amgen Inc
Consultant and Honoraria: TAP Pharmaceutical Products Inc,
Cytogen Corporation, NexCura Inc, Myriad Pharmaceuticals Inc,
Calypso, Sanofi-Synthelabo Inc
Other Support: Siemens
Speakers’ Bureau: TAP Pharmaceutical Products Inc,
AstraZeneca Pharmaceuticals LP |
Robert Dreicer, MD, FACP |
Grants/Research Support, Consultant: Aventis Pharmaceuticals Inc,
Millennium Pharmaceuticals Inc, Celgene Corporation
Speakers’ Bureau: Aventis Pharmaceuticals Inc, Eli Lilly and Company |
Leslie R Schover, PhD |
Grants/Research Support: American Cancer Society National Grant
Principal Investigator |
This educational activity contains discussion of published and/or investigational
uses of agents that are
not indicated by the FDA. NL Communications Inc does not recommend the use
of any agent outside of
the labeled indications. Please refer to the official prescribing information
for each product for discussion
of approved indications, contraindications and warnings. The opinions expressed
are those of the
presenters and are not to be construed as those of the publisher or grantor.
|
|
